Effects of glycine, pyruvate, resveratrol, and nitrite on tissue injury and cytokine response in endotoxemic rats

Journal of Surgical Research

Volumn 183, Issue 1, 2013, Pages

  Hamburger, Tim ^a   Broecker Preuss, Martina ^a   Hartmann, Matthias ^a   Schade, F Ulrich ^a   De Groot, Herbert ^a   Petrat, Frank ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Cytokines; Granulocytes; Ischemia; Kupffer cells; Lipopolysaccharide; Nitric oxide

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BICARBONATE; CHLORIDE; CREATININE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; GAMMA INTERFERON; GLYCINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEMOGLOBIN; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; LACTATE DEHYDROGENASE; LACTIC ACID; NITRATE; NITRITE; POTASSIUM; PYRUVATE SODIUM; RESVERATROL; SODIUM NITRITE; TUMOR NECROSIS FACTOR ALPHA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BICARBONATE BLOOD LEVEL; BIOLOGICAL MONITORING; BLOOD GAS ANALYSIS; BLOOD PH; CARBON DIOXIDE TENSION; CHLORIDE BLOOD LEVEL; CONTINUOUS INFUSION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYTOKINE RESPONSE; DRUG EFFECT; ENDOTOXEMIA; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; HEART; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HEMOLYSIS; HISTOPATHOLOGY; INFLAMMATORY INFILTRATE; KIDNEY; LACTATE BLOOD LEVEL; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER; LOW DRUG DOSE; LUNG; MALE; NONHUMAN; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; SHOCK; SMALL INTESTINE; TISSUE INJURY;

ANIMALS; BLOOD GAS ANALYSIS; BLOOD PRESSURE; CYTOKINES; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; ELECTROLYTES; ENDOTOXEMIA; GLYCINE; HEMATOCRIT; HEMOGLOBINS; LIPOPOLYSACCHARIDES; MALE; PYRUVIC ACID; RATS; RATS, WISTAR; SODIUM NITRITE; STILBENES;

EID: 84879111671     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2013.01.024     Document Type: Article

References (49)

1. J.L. Vincent, E. Carrasco Serrano, and A. Dimoula Current management of sepsis in critically ill adult patients Expert Rev Anti Infect Ther 9 2011 847
2. O.O. Nduka, and J.E. Parrillo The pathophysiology of septic shock Crit Care Clin 25 2009 677
3. X. Wang, and P.J. Quinn Lipopolysaccharide: biosynthetic pathway and structure modification Prog Lipid Res 49 2010 97
4. S.L. Zanotti-Cavazzoni, and R.D. Goldfarb Animal models of sepsis Crit Care Clin 25 2009 703
5. H.D. Wang, D.X. Lu, and R.B. Qi Therapeutic strategies targeting the LPS signaling and cytokines Pathophysiology 16 2009 291
6. M.A. Titheradge Nitric oxide in septic shock Biochim Biophys Acta 1411 1999 437
7. A. Murakami Chemoprevention with phytochemicals targeting inducible nitric oxide synthase Forum Nutr 61 2009 193
8. C.T. Esmon The interactions between inflammation and coagulation Br J Haematol 131 2005 417
9. S. Acikgoz, D. Akduman, and Z. Eskici Thrombocyte and erythrocyte indices in sepsis and disseminated intravascular coagulation J Med Biochem 31 2012 60
10. J. Cohen The immunopathogenesis of sepsis Nature 420 2002 885
11. M. Legrand, E. Klijn, D. Payen, and C. Ince The response of the host microcirculation to bacterial sepsis: does the pathogen matter? J Mol Med 88 2010 127
12. F. Petrat, J. Drowatzky, and K. Boengler Protection from glycine at low doses in ischemia-reperfusion injury of the rat small intestine Eur Surg Res 46 2011 180
13. M.M. Habib, H.J.F. Hodgson, and B.R. Davidson The role of glycine in hepatic ischemia-reperfusion injury Curr Pharm Des 12 2006 2953
14. F. Petrat, T. Rönn, and H. de Groot Protection by pyruvate infusion in a rat model of severe intestinal ischemia-reperfusion injury J Surg Res 167 2011 e93
15. F. Petrat, and H. de Groot Protection against severe intestinal ischemia/reperfusion injury in rats by intravenous resveratrol J Surg Res 167 2011 e145
16. O.V. Ozkan, M.F. Yuzbasioglu, and H. Ciralik Resveratrol, a natural antioxidant attenuates intestinal ischemia/reperfusion injury in rats Tohoku J Exp Med 218 2009 251
17. P. Tripatara, N.S.A. Patel, and A. Webb Nitrite-derived nitric oxide protects the rat kidney against ischemia/reperfusion injury in vivo: role for xanthine oxidoreductase J Am Soc Nephrol 18 2007 570
18. M. Basireddy, T.S. Isbell, X. Teng, R.P. Patel, and A. Agarwal Effects of sodium nitrite on ischemia-reperfusion injury in the rat kidney Am J Physiol Renal Physiol 290 2006 F779
19. R. Bruck, J. Wardi, and H. Aeed Glycine modulates cytokine secretion, inhibits hepatic damage and improves survival in a model of endotoxemia in mice Liver Int 23 2003 276
20. Z. Zhong, M.D. Wheeler, and X. Li L-glycine: a novel antiinflammatory, immunomodulatory, and cytoprotective agent Curr Opin Clin Nutr Metab Care 6 2003 229
21. Q. Wang, M. van Hoecke, and X.N. Tang Pyruvate protects against experimental stroke via an anti-inflammatory mechanism Neurobiol Dis 36 2009 223
22. U.N. Das Pyruvate is an endogenous anti-inflammatory and anti-oxidant molecule Med Sci Monit 12 2006 RA79
23. H. Sebai, M. Sani, M.T. Yacoubi, E. Aouani, N. Ghanem-Boughanmi, and M. Ben-Attia Resveratrol, a red wine polyphenol, attenuates lipopolysaccharide- induced oxidative stress in rat liver Ecotoxicol Environ Saf 73 2010 1078
24. H. Farghali, D. Černý, and L. Kameníková Resveratrol attenuates lipopolysaccharide-induced hepatitis in d-galactosamine sensitized rats: role of nitric oxide synthase 2 and heme oxygenase-1 Nitric Oxide 21 2009 216
25. E.E. Van Faassen, S. Bahrami, and M. Feelisch Nitrite as regulator of hypoxic signaling in mammalian physiology Med Res Rev 29 2009 683
26. N. Aoki, G. Johnson III, and A.M. Lefer Beneficial effects of two forms of NO administration in feline splanchnic artery occlusion shock Am J Physiol Gastrointest Liver Physiol 258 1990 G275
27. C.A. Dinarello Proinflammatory cytokines Chest 118 2000 503
28. R. Devi Ramnath, S. Weing, and M. He Inflammatory mediators in sepsis: cytokines, chemokines, adhesion molecules and gases J Organ Dysfunct 2 2006 80
29. L.C. Green, D.A. Wagner, and J. Glogowski Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids Anal Biochem M126 1982 131
30. F. Petrat, M. Hartmann, E. Schmidt, F. Grabellus, T. Hamburger, and H. de Groot Toluidine blue for the intraoperative staining of the ureters. Studies on the safe administration in rats Langenbecks Arch Surg 397 2012 983
31. C.J. Chiu, A.H. McArdle, R. Brown, H.J. Scott, and F.N. Gurd Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal Arch Surg 101 1970 478
32. P.O. Park, U. Haglund, G.B. Bulkley, and K. Falt The sequence of development of intestinal tissue injury after strangulation ischemia and reperfusion Surgery 107 1990 574
33. J.S. Quaedackers, R.J. Beuk, and L. Bennet An evaluation of methods for grading histologic injury following ischemia/reperfusion of the small bowel Transplant Proc 32 2000 1307
34. H. Sebai, M. Sani, N. Ghanem-Boughanmi, and E. Aouani Prevention of lipopolysaccharide-induced mouse lethality by resveratrol Food Chem Toxicol 48 2010 1543
35. A. Cauwels, E.S. Buys, and R. Thoonen Nitrite protects against morbidity and mortality associated with TNF- or LPS-induced shock in a soluble guanylate cyclase-dependent manner J Exp Med 206 2009 2915
36. F. Petrat, K. Boengler, R. Schulz, and H. de Groot Glycine, a simple physiological compound protecting by yet puzzling mechanism(s) against ischemia-reperfusion injury: current knowledge Br J Pharmacol 165 2001 2059
37. M.P. Fink Ethyl pyruvate Curr Opin Anaesthesiol 21 2008 160
38. M.A. Panaro, V. Carofiglio, A. Acquafredda, P. Cavallo, and A. Cianciulli Anti-inflammatory effects of resveratrol occur via inhibition of lipopolysaccharide-induced NF-kappaB activation in Caco-2 and SW480 human colon cancer cells Br J Nutr 108 2012 1623
39. H. Capiralla, V. Vingtdeux, and H. Zhao Resveratrol mitigates lipopolysaccharide- and Aβ-mediated microglial inflammation by inhibiting the TLR4/NF-κB/STAT signaling cascade J Neurochem 120 2012 461
40. Q. Cao, C. Jing, X. Tang, Y. Yin, X. Han, and W. Wu Protective effect of resveratrol on acute lung injury induced by lipopolysaccharide in mice Anat Rec 294 2011 527
41. M. Larrosa, M. Azorín-Ortuño, M.J. Yanez-Gascón, M.T. García-Conesa, F. Tomás-Barberán, and J.C. Espín Lack of effect of oral administration of resveratrol in LPS-induced systemic inflammation Eur J Nutr 50 2011 673
42. J.F. Marier, P. Vachon, A. Gritsas, J. Zhang, J.P. Moreau, and M.P. Ducharme Metabolism and disposition of resveratrol in rats: extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model J Pharmacol Exp Ther 302 2002 369
43. D. Delmas, A. Lançon, D. Colin, B. Jannin, and N. Latruffe Resveratrol as a chemopreventive agent: a promising molecule for fighting cancer Curr Drug Targets 7 2006 423
44. S. Das, H.S. Lin, P.C. Ho, and K.Y. Ng The impact of aqueous solubility and dose on the pharmacokinetic profiles of resveratrol Pharm Res 25 2008 2593
45. M. Asensi, I. Medina, and A. Ortega Inhibition of cancer growth by resveratrol is related to its low bioavailability Free Radic Biol Med 33 2002 387
46. J.A. Baur, and D.A. Sinclair Therapeutic potential of resveratrol: the in vivo evidence Nat Rev Drug Discov 5 2006 493
47. K. Katsuyama, M. Shichiri, F. Marumo, and Y. Hirata NO inhibits cytokine-induced iNOS expression and NF-κB activation by interfering with phosphorylation and degradation of IκB-α Arterioscler Thromb Vasc Biol 18 1998 1796
48. L. Connelly, M. Palacios-Callender, C. Ameixa, S. Moncada, and A.J. Hobbs Biphasic regulation of NF-κB activity underlies the pro- and anti-inflammatory actions of nitric oxide J Immunol 166 2001 3873
49. C.A. Davies, S.A. Rocks, M.C. O'Shaughnessy, D. Perrett, and P.G. Winyard Analysis of nitrite and nitrate in the study of inflammation Methods Mol Biol 225 2003 305